Concepedia

Publication | Closed Access

Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone.

10

Citations

10

References

2003

Year

Domenico Rendina, Loredana Postiglione, Pietro Vuotto, Numis Fg, Di Domenico G, R. Viceconti, Giuseppe Mossetti, Nunziata
PubMed

Abstract

The decrease in serum sIL-6R levels could be one of the molecular mechanisms that play a role in the clinical response to clodronate treatment in PDB.

References

YearCitations

Page 1